{"id":"W2616235887","doi":"10.1016/s0140-6736(17)30930-3","title":"Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"Pfizer","keywords":"Medicine; Ulcerative colitis; Addressin; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Vedolizumab; Intention-to-treat analysis; Clinical trial; Surgery; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001614795,0.002430405,0.004659522,0.000619657,0.0004604092,0.001195352,0.001084041,0.003012365,0.01068969],"category_scores_gemma":[0.001426851,0.0008919737,0.002301239,0.0005395028,0.001206125,0.001337338,0.0004191404,0.003627217,0.001871394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000638455,"about_ca_system_score_gemma":0.0007895138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00101094,"about_ca_topic_score_gemma":0.002135062,"domain_scores_codex":[0.9995548,0.0001813711,0.000025627,0.00009317407,0.00003650593,0.0001085943],"domain_scores_gemma":[0.9994761,0.0001505373,0.0001084656,0.00003348112,0.00003753382,0.000193964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9742972,0.002609966,0.0002236409,0.001568538,0.0009459435,0.00005886809,0.00003419318,0.000186076,0.00277739,0.0001215489,0.001712186,0.01546448],"study_design_scores_gemma":[0.9790846,0.01933498,0.0005250957,0.000034258,0.0002487287,0.00002468608,0.00001037494,0.00009035753,0.0001207375,0.00005744975,0.0004609643,0.000007886557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9415312,0.03421263,0.001847503,0.003081474,0.003354473,0.007090845,0.00291636,0.0006645705,0.005300999],"genre_scores_gemma":[0.9529117,0.01823373,0.002792384,0.004289736,0.001794853,0.006672053,0.002691114,0.00007544946,0.01053907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01068969,"threshold_uncertainty_score":0.03576064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03194209354831734,"score_gpt":0.3493281749351027,"score_spread":0.3173860813867854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}